Imastop 100 Tablet

Additionally, it targets other tyrosine kinases such as c-KIT and PDGF receptors involved in tumor growth. Imastop 100 is indicated for adult patients diagnosed with Philadelphia chromosome-positive CML in chronic, accelerated, or blast phases, as well as for patients with unresectable and/or metastatic malignant GIST. The recommended dosage and duration of treatment depend on the specific condition and patient response, and therapy should be initiated under specialist supervision.

Common adverse effects include nausea, edema, muscle cramps, rash, and hematologic toxicity, necessitating regular monitoring of blood counts and liver function tests during treatment. Imastop 100 should be used with caution in patients with hepatic impairment and potential drug interactions should be assessed prior to initiation. This medication is a cornerstone in targeted cancer therapy, significantly improving survival and quality of life in affected patients.